Stay updated on Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial page.

Latest updates to the Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedPage revision updated from v3.6.4 to v3.6.5 for the study record, indicating a new version of the page content.SummaryDifference0.0%

- Check22 days agoNo Change Detected
- Check29 days agoChange DetectedThe page's revision tag has been updated from v3.6.3 to v3.6.4, indicating a new build of the page. This update appears to be an internal software revision without changes to the study details or how the page presents information to users.SummaryDifference0.0%

- Check50 days agoChange DetectedRevision tag updated from v3.6.2 to v3.6.3 on the page, indicating a newer build of the Study Details page. The update does not change the study content or user-facing information.SummaryDifference0.0%

- Check58 days agoChange DetectedRevision updated from v3.6.0 to v3.6.2, indicating a page/template update. No study content, eligibility criteria, or results appear to be affected.SummaryDifference0.0%

- Check72 days agoChange DetectedThe page now shows that no participants are being recruited and adds user-focused sections such as How to Read a Study Record, Common Questions, and How to Join a Study, while updating the Intervention/Treatment heading formatting.SummaryDifference0.4%

- Check79 days agoChange DetectedRevision label at the bottom of the page changed from v3.5.4 to v3.5.5, reflecting a small update to the page.SummaryDifference0.0%

Stay in the know with updates to Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Fruquintinib & Tislelizumab in Solid Tumors Clinical Trial page.